Results 61 to 70 of about 1,552 (162)
Abstract Aims Concentrations of high‐sensitivity cardiac troponin T (hs‐cTnT) are frequently elevated in stable patients with confirmed muscle dystrophies. However, sparse information is available on the interpretation of serial concentration changes. Methods Hs‐cTnT was collected in 35 stable outpatients with confirmed skeletal muscle dystrophies at 0
Mustafa Yildirim +10 more
wiley +1 more source
Bethlem myopathy: A novel homozygous variant of c.385C>T (p.Arg129Cys) in the COL6A2 gene
Key Clinical Message This case highlights the challenges in diagnosing Bethlem myopathy, the need for a high index of suspicion, and the importance of recognizing the diverse clinical presentations of this rare condition. Enhanced understanding can aid in early diagnosis and tailored management.
Maryam Kachuei +4 more
wiley +1 more source
The best known muscular dystrophies are X-linked dystrophinopathies. A clinically and genetically heterogeneous group presenting with weakness of the pelvic and shoulder girdles is that of the limb-girdle muscular dystrophies (LGMDs). Sarcoglycanopathies (SGPs) are autosomal recessive LGMDs. We report a rare case of primary gamma-sarcoglycanopathy (SGP)
Sheffali, Gulati +3 more
openaire +1 more source
Loss of Calpain 3 dysregulates store‐operated calcium entry and its exercise response in mice
In resting control skeletal muscles, store operated Ca2+ entry (SOCE) is low, and sarcoplasmic reticulum (SR) Ca2+ stores are high. Exercise depletes SR Ca2+ and triggers SOCE. Loss of Calpain 3 elevates resting SOCE and disrupts exercise induced SOCE.
Katelyn R. Villani +7 more
wiley +1 more source
Engineering Innervated Musculoskeletal Tissues for Regenerative Orthopedics and Disease Modeling
Coupling of the peripheral nervous system to the musculoskeletal system and its implications on tissue engineering strategies for MSK regeneration and disease modeling. Abstract Musculoskeletal (MSK) disorders significantly burden patients and society, resulting in high healthcare costs and productivity loss.
Zhilong Zhou +5 more
wiley +1 more source
[Sarcoglycanopathies: state of the art and therapeutic perspectives].
Sarcoglycanopathies are the third most common cause of autosomal recessive limb girdle muscular dystrophies (LGMD). They are the result of a deficiency in one of the sarcoglycans a, b, g, or d. The usual clinical presentation is that of a symmetrical involvement of the muscles of the pelvic and scapular girdles as well as of the trunk, associated with ...
Fernández-Eulate, Gorka +4 more
openaire +2 more sources
Targeting the ER Quality Control as a novel therapeutic approach for sarcoglycanopathy
Sarcoglycanopathy is a rare genetic disorder mainly affecting the proximal musculature. Defects in any one of the genes coding for α-, β-, δ- or γ-sarcoglycan (SG), four cell-membrane proteins forming an essential complex of striated muscle, lead to the ...
Elisa Bianchini +4 more
core
Sarcoglycans (SG) are glycosylated proteins (α-, β-, γ- or δ-SG) forming a key structural complex, essential for the sarcolemma integrity of striated muscles during contraction.
Elisa Bianchini +5 more
core
International audienceCardiac and respiratory function may be impaired in sarcoglycanopathies, a subgroup of muscular dystrophies due to sarcoglycan proteins (α, β, γ, and δ) genes mutations.
Abdallah Fayssoil +25 more
core +1 more source

